Synthetic lining offers better drug delivery to small intestine

Researchers have developed a synthetic lining that could deliver drugs in a sustained way to the small intestine, offering hope for those suffering from lactose intolerance, diabetes, and obesity.

Harvard Gazette • harvard
Aug. 26, 2020 ~4 min

Tags: science-technology diabetes obesity basic-research brigham-and-womens-hospital gastrointestinal-synthetic-epithelial-lining gsel lactose-intolerance

In soda tax fight, experts hear echoes of tobacco battles

Taxes on sugary drinks are potentially effective tools to fight the obesity epidemic and advocates are drawing lessons from the long battle against tobacco as they plot what they know will be a tough road ahead.

Alvin Powell • harvard
Feb. 18, 2020 ~5 min

Tags:  biotechnology  diabetes  obesity  basic-research  health-medicine  alvin-powell  sugar-sweetened-beverages  petrie-flom-center-for-health-law-policy  harvard-law-school  and-bioethics-emily-broad-leib  carmel-shachar  harvard-medical-school-center-for-bioethics  soda  soda-tax  steven-gortmaker

Researchers able to improve, reverse age-related diseases in mice

Wyss Institute, Harvard Medical School study offers hope for single genetic treatment for multiple age-related ills.

Lindsay Brownell • harvard
Nov. 4, 2019 ~6 min

Tags:  science-technology  health  diabetes  obesity  basic-research  george-church  heart-failure  kidney-failure  lindsay-brownell  noah-davidsohn  rejuvenate-bio

Islet-on-a-chip technology streamlines diabetes research

Islet-on-a-chip technology allows clinicians to easily determine the therapeutic value of beta cells for any given patient.

Mary Bergman • harvard
Aug. 29, 2019 ~6 min

Tags:  science-technology  biotechnology  diabetes  type-2-diabetes  basic-research  otd  douglas-a-melton  organ-on-a-chip

Harvard researchers advance cell therapy for diabetes

A team of researchers led by Harvard University scientists has improved the laboratory process of converting stem cells into insulin-producing beta cells from 30 percent to 80 percent.

Jessica Lau • harvard
May 8, 2019 ~4 min

Tags:  type-1-diabetes  diabetes  health-medicine  insulin  adrian-veres  douglas-melton  felicia-pagliuca  semma-therapeutics  stem-cell

Could a popular food ingredient raise the risk for diabetes and obesity?

Based on new research, a randomized placebo-controlled trial in humans indicates that a popular food ingredient called propionate may raise the risk of diabetes and obesity.

Chris Sweeney • harvard
April 24, 2019 ~5 min

Tags:  diabetes  obesity  health-medicine  harvard-th-chan-school-of-public-health  amir-tirosh  gokhan-s-hotamisligil  propionate

Harvard symposium to tackle increasing diabetes among refugees

Humanitarian workers from around the globe will visit Harvard to discuss how best to treat the increasing number of diabetics among refugee populations. Symposium organizers talk about the problem and what they hope the symposium will accomplish.

Alvin Powell • harvard
April 1, 2019 ~10 min

Tags:  diabetes  global-health  conflict  migration  health-medicine  alvin-powell  harvard-th-chan-school-of-public-health  war  displaced-person  lindsay-jaacks  natural-disaster  refugee  sylvia-kehlenbrink

Microneedle pill takes the sting out of insulin

A team of investigators from Harvard-affiliated Brigham and Women’s Hospital, MIT, and Novo Nordisk has developed a microneedle pill that can deliver an oral formulation of insulin that can be swallowed rather than injected.

Haley Bridger • harvard
Feb. 8, 2019 ~6 min

Tags:  diabetes  mit  health-medicine  brigham-and-womens-hospital  c-giovanni-traverso  insulin  novo-nordisk  robert-langer  self-orienting-millimeter-scale-applicator  soma

Page 1 of 1